ClinicalTrials.govpublic full text
Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.
enterobacteriaceae infections
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 272371
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.